National Cancer Institute; Notice of Closed Meetings, 40162-40163 [2017-17891]

Download as PDF 40162 Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices by law to submit deeming applications in the specified form and manner on behalf of named individuals for review and approval, resulting in a ‘‘deeming determination’’ that includes associated FTCA coverage for these individuals. Need and Proposed Use of the Information: Deeming applications must address certain specified criteria required by law in order for deeming determinations to be issued, and FTCA application forms are critical to BPHC’s deeming determination process. These forms provide BPHC with the information essential for application evaluation and determination of whether an individual meets the requirements for deemed PHS employee status for the purposes of FTCA coverage. Because the 21st Century Cures Act extended FTCA coverage to VHPs, BPHC will add new FTCA application forms for use by health centers applying to sponsor volunteers to become volunteer health professionals with associated FTCA coverage for their activities within the scope of deemed employment on behalf of the health center. Likely Respondents: Respondents include Health Center Program funds recipients seeking deemed PHS employee status on behalf of their sponsored individuals for purposes of FTCA coverage. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, Number of respondents Form name FTCA Health Center Volunteer Health Professional Program Application ............................................................... Total .............................................................................. HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–17926 Filed 8–23–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rmajette on DSKBCKNHB2PROD with NOTICES National Institute of Allergy And Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial VerDate Sep<11>2014 15:29 Aug 23, 2017 Jkt 241001 1375 1375 Number of responses per respondent disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. Total Estimated Annualized Burden Hours: Total responses 3 ........................ 4125 4125 Average burden per response (in hours) Total burden hours 2 ........................ 8250 8250 property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Peer Review Meeting. Date: September 18–19, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Julio Aliberti, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9823, Rockville, MD 20852, 301–761–7322, alibertijc@ niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01). Date: September 27, 2017. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Raymond R. Schleef, Ph.D., Senior Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3E61, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, (240) 669–5019, schleefrr@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, [FR Doc. 2017–17892 Filed 8–23–17; 8:45 am] PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Dated: August 18, 2017. Natasha Copeland, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant and/or contract proposals applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant and/or contract proposals applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel SEER Program. E:\FR\FM\24AUN1.SGM 24AUN1 rmajette on DSKBCKNHB2PROD with NOTICES Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices Date: September 26–27, 2017. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue Bethesda, MD 20814. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Emerging Questions in Cancer Systems Biology. Date: September 28, 2017. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at Chevy Chase Pavilion, 4300 Military Road, Washington, DC 20015. Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Bethesda, MD 20892–9750, 240–276–6342, choe@ mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee J—Career Development. Date: October 17–18, 2017. Time: 6:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892–9750, 240–276–6132, tushar.deb@nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee F—Institutional Training and Education. Date: October 23–24, 2017. Time: 7:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Timothy C. Meeker, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892–9750, 240–276–6464, meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) VerDate Sep<11>2014 15:29 Aug 23, 2017 Jkt 241001 Dated: August 18, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–17891 Filed 8–23–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet in person and via web conference on September 19, 2017, from 9:30am to 5:00pm EDT and September 20, 2017, from 9:30am to 2:00pm EDT. The Board will meet in open session on September 19, 2017, from 9:30am to 12:45pm to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, present a study on the degradation of deoxyribose nucleic acid (DNA) in urine and oral fluid specimens, results from the opioid implementation performance testing (PT) samples, lessons learned from the pilot PT program for oral fluid, and the detection of opioid glucuronides in drug user hair. Public comments are welcome. If you intend to provide public comments, please register and provide a summary of your comments to the contact listed below. The Division of Workplace Programs will review public comments to ensure that they address the topics scheduled to be discussed during the meeting and adhere to the meeting’s established time limits for public comments. The board will meet in closed session on September 19, 2017, from 2:00pm to 5:00pm EDT and on September 20, 2017, from 9:30am to 2:00pm EDT to hear about current confidential practices in the hair testing industry and to discuss proposed revisions of the Oral Fluid Mandatory Guidelines for Federal Workplace Drug Testing Programs. These portions of the meeting are closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). To obtain the web conference call-in numbers and access codes, registration can be completed online at https:// snacregister.samhsa.gov/ MeetingList.aspx. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 40163 Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Brian Makela. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board Dates/Time/Type: September 19, 2017, from 9:30am to 12:45pm, EDT: Open, September 19, 2017, from 2:00pm to 5:00pm, EDT: Closed, September 20, 2017, from 9:30am to 2:00pm, EDT: Closed Place: Parklawn Building, Rooom 5E29, 5600 Fishers Lane, Rockville, Maryland 20857 Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240– 276–2600, Fax: 240–276–2610, Email: brian.makela@samhsa.hhs.gov. Brian Makela, Chemist, Substance Abuse and Mental Health Services Administration. [FR Doc. 2017–17963 Filed 8–23–17; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2017–0723] Public Workshop on Marine Technology and Standards Coast Guard, DHS. Notice; correction. AGENCY: ACTION: The Coast Guard is correcting a notice that appeared in the Federal Register of August 8, 2017. The document announced an upcoming Public Workshop on Marine Technology and Standards to be held on October 16 and 17, 2017 in Washington, DC. The document had an incorrect amount for the registration fee. FOR FURTHER INFORMATION CONTACT: If you have questions about this notice, contact Wayne Lundy, Office of Design and Engineering Standards, USCG, by telephone at (202) 372–1379 or email: Wayne.M.Lundy@uscg.mil. SUPPLEMENTARY INFORMATION: In the Federal Register of August 8, 2017 (82 FR 37104), the Coast Guard published a notice announcing a Public Workshop on Marine Technology and Standards. SUMMARY: E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 82, Number 163 (Thursday, August 24, 2017)]
[Notices]
[Pages 40162-40163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17891]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant and/or contract proposals applications 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel SEER Program.

[[Page 40163]]

    Date: September 26-27, 2017.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue Bethesda, MD 20814.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343, 
schweinfestcw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Emerging Questions in Cancer Systems Biology.
    Date: September 28, 2017.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at Chevy Chase Pavilion, 4300 Military 
Road, Washington, DC 20015.
    Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, 
Bethesda, MD 20892-9750, 240-276-6342, choe@mail.nih.gov.

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee J--Career Development.
    Date: October 17-18, 2017.
    Time: 6:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6132, 
tushar.deb@nih.gov.

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee F--Institutional Training and Education.
    Date: October 23-24, 2017.
    Time: 7:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Timothy C. Meeker, M.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6464, 
meekert@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: August 18, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17891 Filed 8-23-17; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.